Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • BioProtect

CTech 24/7

  • Sony seeks buyer for Israeli chip arm in potential $300M deal
  • Full list of Israeli high-tech funding rounds in 2025
  • Scopio Labs extends Series D with additional $10 million
  • After Intel offloads $1B in shares, Mobileye surges on strong Q2 and new guidance
More stories in CTech

BioProtect

3 stories about BioProtect
  • Itay Barnea BioProtect

    Is it time to reconsider PSA tests for Prostate Cancer?

    01.09.22|Itay Barnea“The treating physician should determine what is best for the patient based on his unique age, family history, health, lifestyle, race, ethnic background, and other factors,” writes Itay Barnea, CEO of BioProtect

  • Doctors. Photo: AFP

    Which Israeli cancer treatment company raised $57 million and who is making money off double chins?

    22.09.20|CTechCTech Daily Roundup: Medtronic invests $4.5 million as part of BioProtect $25 million series D

  • Doctors. Photo: Shutterstock

    Medtronic invests $4.5 million as part of BioProtect $25 million series D

    22.09.20|Meir OrbachProceeds of the round will finance the ongoing multicenter FDA clinical trial of BioProtect's lead product, the ProSpace balloon spacer, which protects prostate cancer patients undergoing radiation therapy

Load more
Ctech Logo
Twitter
Twitter
Facebook
Facebook
NewsLetter
Newsletter
Contact Us
Contact Us
Rss
Rss
About CTech Terms of Use Privacy Policy
Developed by YIT UI & UX by Basch_Interactive